| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| 6α-Hydroxy paclitaxel |
6α-羥基紫杉醇 |
153212-75-0 |
詳細(xì)
|
| Columbia Blood Agar Base |
哥倫比亞血瓊脂基礎(chǔ)培養(yǎng)基 |
|
詳細(xì)
|
| Sabourand's Medium |
沙保羅瓊脂培養(yǎng)基 |
|
詳細(xì)
|
| Anti-TNFSF2 / TNFa Reference Antibody (CDP571) |
|
|
詳細(xì)
|
| Anti-TNFSF2 / TNFa Reference Antibody (golimumab) |
|
|
詳細(xì)
|
| Anti-TrkA / NTRK1 Reference Antibody (GBR 900) |
|
|
詳細(xì)
|
| Anti-TSLP Reference Antibody (tezepelumab) |
ANTI-TSLP REFERENCE ANTIBODY(TEZEPELUMAB) |
|
詳細(xì)
|
| Anti-VEGFR1 / FLT1 Reference Antibody (Abbott patent anti-Flt1) |
|
|
詳細(xì)
|
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (olinvacimab) |
|
|
詳細(xì)
|
| Protease Inhibitor Cocktail for plant cell and tissue extracts(100×) |
植物細(xì)胞裂解蛋白酶抑制劑混合物(100×) |
|
詳細(xì)
|
| cis-9-Hexadecenoic Acid |
順-9-十六碳烯酸 |
373-49-9 |
詳細(xì)
|
| Ampicillin |
氨芐西林 |
69-53-4 |
詳細(xì)
|
| MacConkey Agar |
麥康凱瓊脂培養(yǎng)基 |
|
詳細(xì)
|
| Tween 20 |
吐溫20 |
9005-64-5 |
詳細(xì)
|
| Thidiazuron |
噻苯?。═DZ） |
51707-55-2 |
詳細(xì)
|
| Anti-TNFRSF7 / CD27 Reference Antibody (Organon patent anti-CD27) |
|
|
詳細(xì)
|
| Anti-TNFSF2 / TNFa Reference Antibody (certolizumAb) |
|
|
詳細(xì)
|
| Anti-TNFSF2 / TNFa Reference Antibody (hMAK195) |
|
|
詳細(xì)
|
| Anti-TrkB / NTRK2 Reference Antibody (Rinat patent anti-TrkB) |
|
|
詳細(xì)
|
| Anti-TSPAN26 / CD37 Reference Antibody (AGS67E) |
|
|
詳細(xì)
|
| Anti-VEGFR1 / FLT1 Reference Antibody (icrucumab) |
|
|
詳細(xì)
|
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab) |
|
|
詳細(xì)
|
| Tris-HCl Buffer(10mM,pH8.0) |
Tris-HCl緩沖液(10mM,pH8.0) |
|
詳細(xì)
|
| Cell Preservation Solution |
細(xì)胞保存液 |
|
詳細(xì)
|
| TESCA buffer |
TESCA 緩沖液（pH7.4，無菌） |
|
詳細(xì)
|
| Anti-TROP2 Reference Antibody (sacituzumab) |
ANTI-TROP2 REFERENCE ANTIBODY(SACITUZUMAB) |
|
詳細(xì)
|
| Citric acid trisodium salt |
檸檬酸三鈉鹽 |
|
詳細(xì)
|
| Salmonella Shigella Agar |
SS瓊脂培養(yǎng)基 |
|
詳細(xì)
|
| Anti-TNFRSF7 / CD27 Reference Antibody (varlilumab) |
|
|
詳細(xì)
|
| Anti-TNFSF11 / RANKL / CD254 Reference Antibody (denosumab) |
|
|
詳細(xì)
|
| Anti-TNFSF2 / TNFa Reference Antibody (infliximab) |
|
|
詳細(xì)
|
| Anti-TNFSF7 / CD27L / CD70 Reference Antibody (cusatuzumab) |
|
|
詳細(xì)
|
| Anti-TSPAN26 / CD37 Reference Antibody (lilotomab) |
|
|
詳細(xì)
|
| Anti-VCAM1 / CD106 Reference Antibody (Hanwha patent anti-VCAM-1) |
|
|
詳細(xì)
|
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (vulinacimab) |
|
|
詳細(xì)
|
| CAPS Buffer(0.5M,pH11.0) |
CAPS緩沖液(0.5M,pH11.0) |
|
詳細(xì)
|
| 2,2,2-Tribromoethanol |
2,2,2-三溴乙醇 |
75-80-9 |
詳細(xì)
|
| 0.2% Gelatin Solution |
0.2%的明膠溶液 |
|
詳細(xì)
|
| Potassium chloride |
氯化鉀 |
7447-40-7 |
詳細(xì)
|
| pH 7.0 Dilution Buffer |
|
|
詳細(xì)
|
| Cedar oil |
香柏油 |
8000-27-9 |
詳細(xì)
|
| Tyrode's Solution(HEPES Buffered) |
臺(tái)氏液（HEPES緩沖） |
|
詳細(xì)
|
| SPG buffer(10×,pH9.0) |
SPG緩沖液(10×,pH9.0) |
|
詳細(xì)
|
| DMEM Medium Powder(w/o Glucose,Sodium Pyruvate,w/o HEPES,w/o L-Glutamine,w/o Phenol Red) |
DMEM培養(yǎng)基干粉(無糖,丙酮酸鈉,無HEPES,無L-谷氨酰胺,無酚紅) |
|
詳細(xì)
|
| Anti-VEGFA Reference Antibody (ranibizumab) |
ANTI-VEGFA REFERENCE ANTIBODY(RANIBIZUMAB) |
|
詳細(xì)
|
| Anti-TYRO3 Reference Antibody (ELB031) |
|
|
詳細(xì)
|
| Anti-TPBG Reference Antibody (PF-06263507) |
|
|
詳細(xì)
|
| Anti-TNFSF5 / CD40L / CD154 Reference Antibody (ruplizumab) |
|
|
詳細(xì)
|
| Anti-TNFSF13B / BAFF / CD257 Reference Antibody (belimumab) |
|
|
詳細(xì)
|
| Anti-TNFSF1 / TNFb Reference Antibody (pateclizumab) |
|
|
詳細(xì)
|
| Hemicellulose Activity Assay Kit |
半纖維素酶活性測定試劑盒-分光光度法 |
|
詳細(xì)
|
| Tris-HCl Buffer(1M,pH7.0) |
Tris-HCl緩沖液(1M,pH7.0) |
|
詳細(xì)
|
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (AT001) |
|
|
詳細(xì)
|
| Anti-VEGFB Reference Antibody (CSL346) |
ANTI-VEGFB REFERENCE ANTIBODY (CSL346) |
|
詳細(xì)
|
| Anti-TSHR Reference Antibody (K1-70) |
ANTI-TSHR REFERENCE ANTIBODY(K1-70) |
|
詳細(xì)
|
| Anti-TPSAB1 Reference Antibody (Genentech patent anti-Tryptase Beta 1) |
|
|
詳細(xì)
|
| Anti-TNFSF2 / TNFa Reference Antibody (Epitomics patent anti-TNFα) |
|
|
詳細(xì)
|
| Anti-TNFSF14 / LIGHT / CD258 Reference Antibody (SAR252067) |
|
|
詳細(xì)
|
| Candida Chromogenic Medium |
念珠菌顯色培養(yǎng)基 |
|
詳細(xì)
|
| NaAc Buffer(3M,pH5.2,RNase-free) |
醋酸鈉緩沖液(3M,pH5.2,無RNase) |
|
詳細(xì)
|
| Anti-vWF Reference Antibody (Ajinomoto patent anti-vWF) |
|
|
詳細(xì)
|
| Anti-VEGF Reference Antibody (Domantis patent anti-VEGF) |
|
|
詳細(xì)
|
| Anti-TSPAN26 / CD37 Reference Antibody (otlertuzumab) |
|
|
詳細(xì)
|
| Anti-TNFSF9 / 4-1BBL Reference Antibody (Abbvie patent anti-TNFSF9) |
|
|
詳細(xì)
|
| Anti-TNFSF4 / OX40L / CD252 Reference Antibody (oxelumab) |
|
|
詳細(xì)
|
| Anti-TNFSF13 / APRIL / CD256 Reference Antibody (BION-1301) |
|
|
詳細(xì)
|
| Anti-TNFRSF9 / 4-1BB / CD137 Reference Antibody (urelumab) |
|
|
詳細(xì)
|
| Gentamicin solution（10mg/mL） |
慶大霉素溶液（10mg/mL） |
|
詳細(xì)
|
| Anti-VEGFR3 / FLT4 Reference Antibody (LY3022856) |
|
|
詳細(xì)
|
| Anti-VEGF Reference Antibody (BioMab patent anti-VEGF) |
|
|
詳細(xì)
|
| Anti-TSPAN26 / CD37 Reference Antibody (naratuximab) |
|
|
詳細(xì)
|
| Anti-TNFSF7 / CD27L / CD70 Reference Antibody (vorsetuzumab) |
|
|
詳細(xì)
|
| Anti-TNFSF4 / OX40L / CD252 Reference Antibody (amlitelimab) |
|
|
詳細(xì)
|
| Anti-TNFSF12 / TWEAK Reference Antibody (RO5458640) |
|
|
詳細(xì)
|
| Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab) |
|
|
詳細(xì)
|
| Colcemid Solution(10μg/mL) |
秋水酰胺溶液(10μg/mL) |
|
詳細(xì)
|
| HEPES Buffer(1M,pH7.3) |
HEPES緩沖液(1M,pH7.3) |
|
詳細(xì)
|
| Anti-FLAG（DYKDDDDK）Affinity Agarose |
Anti-FLAG標(biāo)簽（DYKDDDDK）親和凝膠 |
|
詳細(xì)
|
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (Imclone 6.64) |
|
|
詳細(xì)
|
| Anti-VEGFC Reference Antibody (VGX100) |
ANTI-VEGFC REFERENCE ANTIBODY (VGX100) |
|
詳細(xì)
|
| Anti-TSLP Reference Antibody (Schering patent anti-TSLP) |
|
|
詳細(xì)
|
| Anti-TREM1 / CD354 Reference Antibody (PY159) |
|
|
詳細(xì)
|
| Anti-TNFSF2 / TNFa Reference Antibody (ESBA 105) |
|
|
詳細(xì)
|
| Anti-TNFSF2 / TNFa Reference Antibody (adalimumab) |
|
|
詳細(xì)
|
| SPG buffer(10×,pH4.0) |
SPG緩沖液(10×,pH4.0) |
|
詳細(xì)
|
| Anti-vWF Reference Antibody (INSERM patent anti-vWF) |
|
|
詳細(xì)
|
| Anti-VEGFA Reference Antibody (bevacizumab) |
|
|
詳細(xì)
|
| Anti-TSPAN8 Reference Antibody (INSERM patent anti-CO-029) |
|
|
詳細(xì)
|
| Anti-TPBG Reference Antibody (naptumomAb) |
|
|
詳細(xì)
|
| Anti-TNFSF5 / CD40L / CD154 Reference Antibody (dapirolizumab) |
|
|
詳細(xì)
|
| Anti-TNFSF13 / APRIL / CD256 Reference Antibody (sibeprenlimab) |
|
|
詳細(xì)
|
| Anti-TNFRSF9 / 4-1BB / CD137 Reference Antibody (utomilumab) |
|
|
詳細(xì)
|
| RPMI 1640 Medium(Glucose, Bicarbonate Sodium,w/o L-Glutamine,w/o HEPES,Phenol Red,w/o Sodium pyruvate) |
RPMI-1640培養(yǎng)基(葡萄糖,碳酸氫鈉,無L-谷氨酰胺,無HEPES,酚紅,無丙酮酸鈉) |
|
詳細(xì)
|
| MIT, 9.5% |
2-甲基-4-異噻唑啉-3-酮 溶液 |
|
詳細(xì)
|
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (alacizumAb) |
|
|
詳細(xì)
|
| Anti-VEGFA Reference Antibody (varisacumab) |
|
|
詳細(xì)
|
| Anti-TRP1 / TYRP1 Reference Antibody (flanvotumab) |
|
|
詳細(xì)
|
| Anti-TPBG Reference Antibody (Wyeth patent anti-5T4) |
|
|
詳細(xì)
|
| Anti-TNFSF2 / TNFa Reference Antibody (CMAB008) |
|
|
詳細(xì)
|
| Anti-TNFSF13B / BAFF / CD257 Reference Antibody (tabalumab) |
|
|
詳細(xì)
|